TREATMENT OF BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION WITH INTRAVITREAL STEROID IMPLANTS

Retin Cases Brief Rep. 2022 Jul 1;16(4):461-465. doi: 10.1097/ICB.0000000000001008. Epub 2020 Jul 7.

Abstract

Background/purpose: To report a case of bilateral diffuse uveal melanocytic proliferation (BDUMP) treated with intravitreal steroid implants.

Method: Bilateral diffuse uveal melanocytic proliferation was diagnosed and treated with intravitreal steroid implants (both dexamethasone 0.7 mg [intravitreal dexamethasone implants] and fluocinolone acetonide 0.18 mg [intravitreal fluocinolone acetonide implants]) and monitored every 2 weeks to 4 weeks with optical coherence tomography.

Results: Intravitreal dexamethasone implants improved visual acuity and central retinal thickness for 10 weeks, was best from 4 to 6 weeks, and recurred by 14 weeks after treatment. Intravitreal fluocinolone acetonide implants improved visual acuity and central retinal thickness for 20 weeks after treatment without edema recurrence. No retinal detachments were observed over 1 year of treatment.

Conclusion: Intravitreal steroid implants resulted in visual acuity improvement and central retinal thickness reduction for up to 20 weeks and may protect against retinal detachments in patients with bilateral diffuse uveal melanocytic proliferation.

Publication types

  • Case Reports

MeSH terms

  • Cell Proliferation
  • Dexamethasone
  • Drug Implants
  • Fluocinolone Acetonide*
  • Glucocorticoids / adverse effects
  • Humans
  • Intravitreal Injections
  • Retinal Neoplasms*
  • Tomography, Optical Coherence
  • Visual Acuity

Substances

  • Drug Implants
  • Glucocorticoids
  • Fluocinolone Acetonide
  • Dexamethasone